Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Ongoing clinical trials of TYSABRI
Snake bite-induced leucoencephalopathy.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Physical Activity in Multiple Sclerosis: A Comparative Study of Vitamin D, Brain-Derived Neurotrophic Factor and Regulatory T Cell Populations.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
Multiple sclerosis in New Zealand.
The incidence of clinically isolated syndrome in a multi-ethnic cohort.
B-cell depletion in children with neuroimmunologic conditions: The learning curve.
The multiple sclerosis self-management scale: clinicometric testing.
Microanatomy and histological features of central myelin in the root exit zone of facial nerve.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Laquinimod in the treatment of relapsing remitting multiple sclerosis.
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia.
B Cells and Autoantibodies in Multiple Sclerosis.
Relapsing optic neuritis: a multicentre study of 62 patients.
Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »